Radioactivity in blood and urine following intraperitoneal instillation of chromic phosphate in patients with and without ascites

Systemic distribution of radioactive colloidal chromic phosphate P 32 after intraperitoneal instillation was studied in 10 patients with ovarian or endometrial malignancies. Seven patients without ascites received chromic phosphate P 32 for positive peritoneal washings, rupture of the capsule of the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Am. J. Obstet. Gynecol.; (United States) 1984-09, Vol.150 (2), p.184-188
Hauptverfasser:	Bakri, Younes N., Given, Fred T.
Format:	Artikel
Sprache:	eng
Schlagworte:	550604 - Medicine- Unsealed Radionuclides in Therapy- (1980-) Adult Aged ASCITES Ascites - blood Ascites - complications Ascites - radiotherapy Ascites - urine BETA DECAY RADIOISOTOPES BETA-MINUS DECAY RADIOISOTOPES BIOLOGICAL MATERIALS BIOLOGICAL WASTES BLOOD BODY BODY FLUIDS Brachytherapy Chromium - blood Chromium - urine Chromium Compounds COLLOIDS DAYS LIVING RADIOISOTOPES DISEASES DISPERSIONS Female FEMALE GENITALS GONADS Humans INJECTION INTAKE INTRAPERITONEAL INJECTION ISOTOPES Kinetics LIGHT NUCLEI MATERIALS MEDICINE Middle Aged NEOPLASMS NUCLEAR MEDICINE NUCLEI ODD-ODD NUCLEI ORGANS Ovarian Neoplasms - blood Ovarian Neoplasms - complications Ovarian Neoplasms - radiotherapy Ovarian Neoplasms - urine OVARIES PATHOLOGICAL CHANGES PATIENTS Phosphates - blood Phosphates - urine PHOSPHORUS 32 PHOSPHORUS ISOTOPES Phosphorus Radioisotopes - blood Phosphorus Radioisotopes - therapeutic use Phosphorus Radioisotopes - urine RADIOACTIVITY RADIOCOLLOIDS RADIOISOTOPES RADIOLOGY RADIOLOGY AND NUCLEAR MEDICINE RADIOTHERAPY RETENTION SYMPTOMS THERAPY URINE Uterine Neoplasms - blood Uterine Neoplasms - complications Uterine Neoplasms - radiotherapy Uterine Neoplasms - urine WASTES
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Systemic distribution of radioactive colloidal chromic phosphate P 32 after intraperitoneal instillation was studied in 10 patients with ovarian or endometrial malignancies. Seven patients without ascites received chromic phosphate P 32 for positive peritoneal washings, rupture of the capsule of the cyst during operation, or minimal Stage III disease. Three patients received chromic phosphate P 32 for recurrent ascites after multiple abdominal paracenteses. Blood and urine radioactivity measurements were performed at selected intervals. There was a clear statistically significant difference (p < 0.01) between chromic phosphate P 32 activity levels in whole blood, red blood cells, and plasma in patients with and without ascites.
ISSN:	0002-9378 1097-6868
DOI:	10.1016/S0002-9378(84)80014-9